Y

Yi Zhang

Tianjin Medical University General Hospital

ORCID: 0000-0001-9861-4681

Publishes on Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction, CAR-T cell therapy research. 2.2k papers and 98.7k citations.

PubIndex Score98Top 2%How it's scored

2.2kPublications

98.7kTotal Citations

First publication: 1997First senior author: 2002

Cancer Immunotherapy and Biomarkers Immune Cell Function and Interaction CAR-T cell therapy research Immunotherapy and Immune Responses MicroRNA in disease regulation

Top publicationsby citations

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Fei Zhou, Bin Cao, Ting Yu et al.|The Lancet|2020

Cited by 29.1k

A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

Bin Cao, Chunmin Jia, Nanshan Chen et al.|New England Journal of Medicine|2020

Cited by 5.5k

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

Yeming Wang, Chen Wang, Dingyu Zhang et al.|The Lancet|2020

Cited by 3.7k

Roles of IFN-γ in tumor progression and regression: a review

Dragica Jorgovanović, Yi Zhang|Biomarker Research|2020

Cited by 1.2k

Association of Plasma Clusterin Concentration With Severity, Pathology, and Progression in Alzheimer Disease

Madhav Thambisetty, Simon Lovestone, Andrew Simmons et al.|Archives of General Psychiatry|2010

Cited by 402